ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. The company was founded in 2004 and is headquartered in Oakwood, Ohio.
Revenue of ViewRay, Inc. (VRAY)
Revenue in 2022 (TTM): $102.21 M
According to ViewRay, Inc.'s latest financial reports the company's current revenue (TTM) is $102.21 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of ViewRay, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2022 | $102.21 M | $10.05 M | $-100,457,000 | $-107,330,000 | $-107,533,000 |
| 2021 | $70.12 M | $335 K | $-105,807,000 | $-110,048,000 | $-106,134,000 |
| 2020 | $57.02 M | $-4,059,000 | $-104,601,000 | $-107,908,000 | $-105,381,000 |
| 2019 | $87.78 M | $-5,478,000 | $-115,872,000 | $-120,199,000 | $-123,073,000 |
| 2018 | $80.96 M | $6.6 M | $-68,695,000 | $-76,396,000 | $-76,396,000 |
| 2017 | $34.04 M | $6.33 M | $-62,732,000 | $-72,176,000 | $-72,176,000 |
| 2016 | $22.24 M | $-3,629,000 | $-44,685,000 | $-50,636,000 | $-50,636,000 |
| 2015 | $10.39 M | $-4,154,000 | $-41,542,000 | $-44,994,000 | $-44,995,000 |
| 2014 | $ | $ | $ | $ | $ |
| 2013 | $3.16 M | $-5,028,000 | $-26,041,000 | $-27,222,000 | $-27,222,000 |